GlassScriptPhysician profile
Charlotte Ekstrom
NPI 1558106898
$2,838.57
in general payments reported to CMS, 2019-2025
39 companies · $2,839 in 2025
The $2,839 reported for 2025 was more than what 96% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394 · Education: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.83 |
| Education | $444.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $309.96 | 2025 | Keytruda, Keytruda Qlex, Lynparza |
| Ipsen Biopharmaceuticals, INC | $198.28 | 2025 | Onivyde |
| Abbvie INC. | $172.97 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $170.20 | 2025 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $154.79 | 2025 | Imfinzi, Enhertu, Lynparza |
| Lilly USA, LLC | $137.00 | 2025 | Verzenio, Jaypirca |
| Pfizer INC. | $130.13 | 2025 | |
| Sobi, INC | $125.38 | 2025 | |
| Incyte Corporation | $120.74 | 2025 | Monjuvi, Jakafi, Zynyz |
| Daiichi Sankyo INC. | $116.82 | 2025 | Enhertu, Datroway |
| Celgene Corporation | $93.84 | 2025 | Reblozyl, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $85.45 | 2025 | Opdivo |
| Stemline Therapeutics INC. | $85.04 | 2025 | Orserdu |
| Beone Medicines USA, INC. | $71.64 | 2025 | Brukinsa |
| Bayer Healthcare Pharmaceuticals INC. | $65.87 | 2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlotte Ekstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.